In this section of the General Tradeshow News Site, you'll find event-related news releases from PR Newswire. The releases are listed in chronological order and are archived by month and year.
Mize to showcase mWarranty, Next Generation warranty management software to streamline Warranty Registrations, Claims, Returns, Supplier Recovery, Service Plans, Service Campaigns and Warranty insights.
First study of its kind to be published in CHEST shows how comprehensive tele-ICU programs are impacting financial outcomes, driving substantial cost savings
Tecate Fight of the Year Award Goes to Epic Francisco Vargas vs. Orlando Salido Draw, Making Vargas the First Fighter Ever to Win Back-to-Back WBC Fight of the Year Awards
Study using real-world evidence demonstrates potential for increased understanding of mantle cell lymphoma patients from adding comorbidity view with disease-specific view
Visionary Futurist Andrew McAfee, ABC News Senior Legal Correspondent & The View Co-Host Sunny Hostin, Supreme Court Justices, Fortune 500 General Counsels and AmLaw 100 Leaders Among Featured Speakers at Inaugural Event Hosted by ALM
- Provides genomic information to help guide treatment decisions in ER+ breast cancer including those at risk for late recurrence and likely to benefit from extended anti-estrogen therapy
Join hundreds of accountable care pioneers to learn how rural and urban hospitals, clinics, small practices and independent providers can achieve better outcomes and higher earnings.
High concordance of the Company's Target-Selector™ platform enables real-time monitoring of key biomarkers in metastatic breast cancer, and provides an alternative when tissue biopsy is not an option
The Creators Update, as well as key partnerships with Intel and Qualcomm, sets the stage for more innovative hardware and experiences for customers in 2017.
Results demonstrate high level of analytical sensitivity and specificity for the Company's non-invasive, clinically actionable biomarker test for immunotherapy
- New Phase 2 data presented at the American Society of Hematology Annual Meeting highlight potential role of ibrutinib therapy beyond hematologic cancers